Zydus Cadila gets USFDA nod for schizophrenia treatment drug

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Brexpiprazole tablets in the strength of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, the drug firm said in a statement.

from Moneycontrol Business News https://ift.tt/3jXUzSC